David Bautz
Analyst-Equity at Zacks Investment Research, Inc. (Small Cap Research)
Profile
Dr. David Bautz is a Senior Biotechnology Analyst at Zacks Investment Research, Inc. He joined the firm in February 2014.
Dr. Bautz worked for two years as a Research Associate at Human Genome Sciences, Inc., a biotechnology company that was eventually acquired by GlaxoSmithKline.
He obtained his PhD in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill in 2008.
His dissertation research focused on the characterization of autoantibodies in patients suffering from an orphan autoimmune disease.
He obtained his BS and MS degrees in Biochemistry from Virginia Tech.
David Bautz active positions
| Companies | Position | Start |
|---|---|---|
| Zacks Investment Research, Inc. (Small Cap Research) | Analyst-Equity | 2014-01-31 |
Training of David Bautz
| The University of North Carolina at Chapel Hill | Doctorate Degree |
| Virginia Polytechnic Institute & State University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
| Zacks Investment Research, Inc. (Small Cap Research) | Finance |
- Stock Market
- Insiders
- David Bautz
